Test Price
2,800 AED✅ Home Collection Available
COX6A1 Gene NGS Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (Available daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Core Metric: Next-Generation Sequencing (NGS) whole gene analysis with coverage of coding regions, splice sites, and deep intronic variants.
Test Overview & Methodology
The COX6A1 gene NGS test screens for pathogenic variants associated with mitochondrial dysfunction, particularly complex IV deficiency, presenting as encephalopathy, Leigh syndrome, or ataxia. This advanced genetic analysis provides a definitive molecular diagnosis for precise clinical management.
| Feature | Our COX6A1 NGS Test | Closest Alternative |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – whole gene analysis | Sanger sequencing / limited exon panel |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Diagnostic Depth | Covers all coding regions, splice sites, and deep intronic variants | Targets hotspots only, may miss novel/potential variants |
| Price | 2,800 AED | 3,500+ AED |
| Regulatory Compliance | DHA/MOHAP Approved, ISO 9001:2015, Federal Decree-Law No. 45 of 2021 (PDPL) | Variable |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I consider the COX6A1 NGS test an essential tool for diagnosing mitochondrial complex IV deficiency in patients presenting with unexplained neurological decline. However, results must be interpreted within the full clinical context, including brain imaging, metabolic profiling, and family history. Gene-directed therapies should only be initiated after comprehensive clinical correlation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Advisory – Medication and Treatment
Do not discontinue, adjust, or initiate any prescribed medication or therapy based solely on genetic test results without consulting your treating physician. Genetic findings must always be validated by clinical judgment.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Unsupervised minors (under 18) without legal guardian consent; patients with acute unstable critical illness; active infection at phlebotomy site; inability to provide informed consent under Federal Decree-Law No. 4 of 2016 on Medical Liability and Federal Decree-Law No. 45 of 2021 (PDPL).
- Emergency Red Flags – Seek immediate medical attention if you experience: new-onset seizures, rapid neurological deterioration, loss of consciousness, severe headache with vomiting, or signs of stroke.
Patient FAQ & Clinical Guidance
1. What conditions does the COX6A1 gene test detect?
This NGS test identifies pathogenic variants in the COX6A1 gene linked to mitochondrial complex IV deficiency, presenting as encephalopathy, Leigh syndrome, or ataxia. It provides a definitive molecular diagnosis to guide personalized management.
2. Is home collection available across the UAE?
Yes, our ISO-certified VIP mobile phlebotomy service is available daily from 8 AM to 11 PM in Dubai, Abu Dhabi, Sharjah, and all Emirates. The sample is transported under temperature-controlled cold-chain to our CAP-accredited laboratory.
3. How should I prepare for the test?
Genetic counseling is mandatory per DHA guidelines. You must provide a detailed clinical history, a three-generation pedigree chart, and any prior neuroimaging or metabolic reports. No special dietary preparation is required.
4. What is the turnaround time for results?
Results are typically available within 3–4 weeks from sample receipt. You will receive a comprehensive molecular report with variant classifications per ACMG guidelines and a telephonic consultation with our geneticist.
UAE Regulatory & Data Privacy Adherence
🔐 Data Protection & Legal Compliance
DNA Labs UAE operates under DHA Facility License No. 1143. All genetic data processing adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic information is encrypted, access-controlled, and never shared without explicit consent. Informed consent follows Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | COX6A1 Gene Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) – VIP Mobile Phlebotomy available |
| Methodology Used | Next-Generation Sequencing (NGS) – Whole gene analysis |
| ICD-10-CM Code | E88.49 (Other mitochondrial metabolism disorders) |
| LOINC Code | 82939-0 (Genetics test) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians